A recent study found that MTA1 silencing in human prostate cancer PC3M cells diminished formation of bone metastases and impaired tumor growth in intracardiac and subcutaneous prostate cancer xenografts, respectively (51). Here, MTA1 is linked to prostate carcinoma.